These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12865385)

  • 21. Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 2002 Jan; 49(1):189-92. PubMed ID: 11751787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S; Ianniello F; Leone S; Esposito S
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
    Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park.
    Odendaal MW; Pieterson PM; de Vos V; Botha AD
    Onderstepoort J Vet Res; 1991 Mar; 58(1):17-9. PubMed ID: 1905000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ketolide antibiotics with a fused five-membered lactone ring--synthesis, physicochemical and antimicrobial properties.
    Hunziker D; Wyss PC; Angehrn P; Mueller A; Marty HP; Halm R; Kellenberger L; Bitsch V; Biringer G; Arnold W; Stämpfli A; Schmitt-Hoffmann A; Cousot D
    Bioorg Med Chem; 2004 Jul; 12(13):3503-19. PubMed ID: 15186835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
    Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman M; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacillus anthracis and antibacterial agents.
    Bryskier A
    Clin Microbiol Infect; 2002 Aug; 8(8):467-78. PubMed ID: 12197869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates.
    Zarazaga M; Sáenz Y; Portillo A; Tenorio C; Ruiz-Larrea F; Del Campo R; Baquero F; Torres C
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3039-41. PubMed ID: 10582908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-thiolated beta-lactams: a new family of anti-Bacillus agents.
    Turos E; Long TE; Heldreth B; Leslie JM; Reddy GS; Wang Y; Coates C; Konaklieva M; Dickey S; Lim DV; Alonso E; Gonzalez J
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2084-90. PubMed ID: 16473509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis.
    Byun Y; Vogel SR; Phipps AJ; Carnrot C; Eriksson S; Tiwari R; Tjarks W
    Nucleosides Nucleotides Nucleic Acids; 2008 Mar; 27(3):244-60. PubMed ID: 18260009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
    Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG
    Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens.
    Nomura T; Yasukata T; Narukawa Y; Uotani K
    Bioorg Med Chem; 2005 Nov; 13(21):6054-63. PubMed ID: 15994088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis.
    Kihira T; Sato J; Shibata T
    J Infect Chemother; 2004 Apr; 10(2):97-100. PubMed ID: 15160302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
    Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
    J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.